3,4-dihydroxyphenylacetaldehyde has been researched along with 3-methoxytyramine in 1 studies
| Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (3-methoxytyramine) | Trials (3-methoxytyramine) | Recent Studies (post-2010) (3-methoxytyramine) |
|---|---|---|---|---|---|
| 99 | 0 | 50 | 364 | 3 | 90 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranyi, M; Gagov, H; Kalfin, R; Petkova-Kirova, P; Rakovska, A; Windisch, K | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and 3-methoxytyramine
| Article | Year |
|---|---|
Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Electric Stimulation; Extracellular Space; Homovanillic Acid; Humans; Male; Mice; Nerve Tissue Proteins; Norepinephrine; Nucleus Accumbens; Peptide Fragments; Phenylethyl Alcohol; Reward; Tissue Culture Techniques | 2017 |